Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Yu Sato1, Sho Torii1, Kenji Kawai1

  • 1CVPath Institute Inc, Gaithersburg, MD (Y.S., S.T., K.K., K.Y., M.K., R. Kawakami, T.K., A.E.V., H.J., A.S., H.M., A.C., M.M., T.T., T.S., R. Kutys, S.K.B.G., M.E.R., F.D.K., R.V., A.V.F.).

Insights

Hypoattenuated leaflet thickening (HALT) in transcatheter aortic valves is confirmed as thrombus progression. Early detection and treatment are crucial before thrombus organization for optimal outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Pathology

Background:

  • Hypoattenuated leaflet thickening (HALT) is a suspected indicator of leaflet thrombosis in transcatheter aortic valves.
  • No prior systematic histological examination of HALT has been conducted.

Purpose of the Study:

  • To evaluate histological findings of explanted self-expanding transcatheter aortic bioprosthetic valves.
  • To compare microCT findings of suspected HALT with histological findings of valve thrombosis and its temporal characterization.

Main Methods:

  • 123 self-expanding transcatheter aortic valves were collected from clinical trials via autopsy or explant.
  • Histological analysis of valve leaflets was performed, with microCT imaging used to assess HALT.
  • Exclusion criteria included infective endocarditis and transcatheter aortic valve-in-surgical aortic valve procedures.

Main Results:

  • Leaflet thickening was observed in 46.5% of leaflets and histologically confirmed as acute, organizing, or organized thrombus (pannus).
  • Thrombus was acute in valves implanted <30 days, and mostly organized in valves implanted >30 days.
  • MicroCT imaging could not differentiate thrombus types.

Conclusions:

  • HALT signifies thrombus presence and progression in transcatheter aortic valves.
  • Treatment is likely most effective in early stages before thrombus organization.
  • Early detection of HALT is essential for timely intervention.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...